✦ LIBER ✦

Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2/HER1-negative breast cancer

✍ Scribed by Hideya Onishi; Takashi Morisaki; Yuji Nakafusa; Yutaka Nakashima; Kazunori Yokohata; Mitsuo Katano

Book ID: 106285393
Publisher: Springer
Year: 2011
Tongue: English
Weight: 303 KB
Volume: 16
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-011-0195-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting HER 1 and 2 in breast cancer w

Targeting HER 1 and 2 in breast cancer with lapatinib

✍ Gerald M. Higa 📂 Article 📅 2008 🏛 PAGEPress Publications 🌐 English ⚖ 119 KB

Immunohistochemical expression of HER1,

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

✍ Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Akihiro Hirakawa; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

Human epidermal growth factor receptor 2

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy

✍ Allan Lipton; Kim Leitzel; Suhail M. Ali; Walter Carney; Greg Platek; Klaudia St 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

Role of trastuzumab in patients with bra

Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer

✍ Nilufer Bulut; Hakan Harputluoglu; Omer Dizdar; Kadri Altundag 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 84 KB

Survival in patients with brain metastas

Survival in patients with brain metastases from breast cancer : The importance of HER-2 status

✍ April F. Eichler; Irene Kuter; Paula Ryan; Lidia Schapira; Jerry Younger; John W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i

Trastuzumab prolongs overall survival in

Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer

✍ Rupert Bartsch; Andrea Rottenfusser; Catharina Wenzel; Karin Dieckmann; Ursula P 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 162 KB